Satyanarayana Reddy Karri

Satyanarayana Reddy Karri

Directeur/Bestuurslid bij Hyacinths Pharma Pvt Ltd.

Process Industries

Oorsprong van het eerstegraads netwerk van Satyanarayana Reddy Karri

EntiteitType entiteitIndustrie
2
Subsidiary Chemicals: Major Diversified 2

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Satyanarayana Reddy Karri via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Engineering & Construction

Kambam Nithyananda Reddy

Venkateswararao Kondreddy

Director/Board Member

Director/Board Member

Chemicals: Specialty

Kambam Nithyananda Reddy

Venkateswararao Kondreddy

Director/Board Member

Director/Board Member

AUROBINDO PHARMA Pharmaceuticals: Other

Kambam Nithyananda Reddy

Founder

Pharmaceuticals: Major

Kambam Nithyananda Reddy

Director/Board Member

APL Research Centre Ltd.

Kambam Nithyananda Reddy

Director/Board Member

Pharmaceuticals: Major

Kambam Nithyananda Reddy

Director/Board Member

Pharmaceuticals: Major

Kambam Nithyananda Reddy

Director/Board Member

Medical Specialties

Kambam Nithyananda Reddy

Director/Board Member

Patancheru Envirotech Ltd.

Kambam Nithyananda Reddy

Director/Board Member

Pharmaceutical Export Promotion Council General Government

Kambam Nithyananda Reddy

Director/Board Member

Pharmaceuticals: Major

Kambam Nithyananda Reddy

Director/Board Member

Sri Venkateswara University College/University

Kambam Nithyananda Reddy

Graduate Degree

Apitoria Pharma Pvt Ltd.

Kambam Nithyananda Reddy

Director/Board Member

Pharmaceuticals: Other

Kambam Nithyananda Reddy

Founder

Aurobindo Pharma Foundation Investment Trusts/Mutual Funds

Kambam Nithyananda Reddy

Director/Board Member

Statistieken

Internationaal

India 15
Duitsland 2

Sectoraal

Health Technology 8
Industrial Services 2
Process Industries 2
Government 2
Consumer Services 2

Operationeel

Director/Board Member 17
Founder 2
Chief Executive Officer 1
Corporate Officer/Principal 1
President 1
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU